CIC bioGUNE, Parque tecnológico de Bizkaia, Bizkaia, Spain.
Prion. 2009 Oct-Dec;3(4):220-3. doi: 10.4161/pri.3.4.10500. Epub 2009 Oct 30.
Protein Misfolding Cyclic Amplification (PMCA) has proved to be an efficient method mimicking in vitro some of the fundamental steps involved in prion replication in vivo. Thus, it can be used to efficiently replicate a variety of prion strains/species. The in vitro generated prions possess key prion features, i.e., they are infectious in vivo and maintain their strain specificity. One of the big challenges is its use for studying prion transmission barriers. PMCA has been efficiently used for adapting different prion species through a range of species barriers; however its capacity for overcoming purportedly unbreakable species barriers compels us to adapt it in order to use it as a reliable technique. In addition, this in vitro method might be a crucial tool in evaluating the potential risks of different prion strains (natural or experimentally generated in vitro) to humans and animals.
蛋白质错误折叠循环扩增(PMCA)已被证明是一种有效的方法,可以模拟体内朊病毒复制的一些基本步骤。因此,它可以有效地复制各种朊病毒株/种。体外产生的朊病毒具有关键的朊病毒特征,即它们在体内具有感染性,并保持其株特异性。其中一个大的挑战是将其用于研究朊病毒传播障碍。PMCA 已被有效地用于通过一系列物种障碍来适应不同的朊病毒物种;然而,它克服据称不可逾越的物种障碍的能力迫使我们对其进行调整,以便将其用作可靠的技术。此外,这种体外方法可能是评估不同朊病毒株(天然或体外实验产生)对人类和动物潜在风险的关键工具。